Orasure Technologies Inc.

This committee provides the official revenue estimates for all tax bills and directly influences corporate tax structures and capital investment credits. Its technical analysis is critical for shaping the tax policy landscape that directly impacts Orasure Technologies' financial performance and investment decisions.

This powerful committee controls taxation, trade, and entitlement spending (e.g., Medicare pricing), all of which directly affect corporate valuations, profitability, customer reimbursement, and market access for medical instrument manufacturers like Orasure Technologies.

This committee directly allocates discretionary federal spending across all government functions. Its subcommittees determine precise funding for healthcare programs, scientific research, and agency procurement, directly influencing potential revenue streams or market opportunities for medical instrument manufacturers.

This committee directly regulates the FDA, which has primary oversight over medical devices manufactured by Orasure Technologies. Its decisions on drug approval, NIH funding, and labor laws have a direct, material impact on the company's products, research, and operating costs.

This committee directly oversees the Department of Veterans Affairs, whose funding decisions and procurement needs directly impact medical device manufacturers, offering committee members insights into upcoming demand or budget allocations for medical instruments.

This committee's oversight of government procurement directly impacts federal contracting opportunities for medical instrument manufacturers like Orasure Technologies, potentially providing members with non-public information on future government needs or contracts.